EP3270909
Samsetningar með föstum skammti sem innihalda ETC1002 og eitt eða fleiri statín til meðhöndlunar eða lækkunar á hjarta- og æða-áhættu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.3.2016EP published:
1.11.2023EP application number:
16765682.6
EP translation filed:
22.1.2024Grant published:
15.2.2024EPO information:
European Patent Register
Max expiry date:
15.3.2036Expiry date:
15.3.2027Next due date:
31.3.2027
Title in English:
FIXED DOSE COMBINATIONS COMPRISING ETC1002 AND ONE OR MORE STATINS FOR TREATING OR REDUCING CARDIOVASCULAR RISKLanguage of the patent:
English
Timeline
Today
16.3.2016EP application
1.11.2023EP Publication
22.1.2024Translation submitted
15.2.2024Registration published
15.3.2027Expires
Owner
Name:
Esperion Therapeutics, Inc.Address:
3891 Ranchero Drive Suite 150, Ann Arbor, MI 48108, US
Inventor
Name:
NEWTON, Roger SchofieldAddress:
Ann Arbor, MI 48108, US
Name:
ROSENBERG, Noah LabanAddress:
Ann Arbor, MI 48108, US
Name:
MACDOUGALL, Diane ElaineAddress:
Ann Arbor, MI 48108, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562133739 PDate:
16.3.2015Country:
US
Number:
201662277403 PDate:
11.1.2016Country:
US
Classification
Categories:
A61K 31/194, A61P 9/10, A61P 3/06, A61K 31/20, A61K 31/22, A61K 31/366, A61K 31/40, A61K 31/405, A61K 31/47, A61K 31/505, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 22.1.2024
Expires: 15.3.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 13.2.2025
Expires: 15.3.2026
Payer: Árnason Faktor ehf.
Number: 11
Paid: 20.3.2026
Expires: 15.3.2027
Payer: Árnason Faktor ehf.